| 标题 |
Abstract CT021: Preliminary safety and clinical activity of zoldonrasib (RMC-9805), an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with previously treated KRAS G12D non-small cell lung cancer (NSCLC) |
| 网址 | |
| DOI |
10.1158/1538-7445.am2026-ct021
doi
|
| 其它 |
期刊:Cancer Research 作者:Jonathan Riess; Eric B. Haura; Rona Yaeger; Melissa Johnson; Jia Luo; et al 出版日期:2026-05-15 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)